396412003: Tetanus toxoid (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1764329010 Tetanus toxoid (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1776350017 Tetanus toxoid en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3265071000005114 tetanustoxoid da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
tetanustoxoid	Is a	toxoid	false	Inferred relationship	Some
tetanustoxoid	Is a	Allergen class	false	Inferred relationship	Some
tetanustoxoid	Is a	Drug allergen	false	Inferred relationship	Some
tetanustoxoid	Is a	tetanusvaccine	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Administration of first dose of tetanus vaccine	Direct substance	False	tetanustoxoid	Inferred relationship	Some	1
Administration of second dose of tetanus vaccine	Direct substance	False	tetanustoxoid	Inferred relationship	Some	1
Administration of third dose of tetanus vaccine	Direct substance	False	tetanustoxoid	Inferred relationship	Some	1
Administration of booster dose of tetanus vaccine	Direct substance	False	tetanustoxoid	Inferred relationship	Some	1
Administration of final dose of vaccine product containing only Clostridium tetani antigen (procedure)	Direct substance	False	tetanustoxoid	Inferred relationship	Some	1
Equine rhinopneumonitis - influenza vaccine - tetanus toxoid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Intramuscular injection of human tetanus immunoglobulin	Direct substance	False	tetanustoxoid	Inferred relationship	Some
adsorberet difteri- + tetanusvaccine injektionsvæske, suspension i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
adsorberet difteri- + tetanusvaccine (til voksne og unge) injektionsvæske, suspension i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
adsorberet difteri- + tetanusvaccine (til voksne og unge) injektionsvæske, suspension, ampul a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
adsorberet difteri- + tetanusvaccine (til voksne og unge) injektionsvæske, suspension, hætteglas a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
tetanusvaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
adsorberet tetanusvaccine injektionsvæske, opløsning i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Haemophilus influenzae type B (Hib)-/difteri-/tetanus-/kighostevaccine hætteglas + fyldt sprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Haemophilus influenzae type B (Hib)- + difteri- + tetanus- + kighostevaccine i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Haemophilus influenzae type b (Hib)-/difteri-/tetanus-/kighostevaccine hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
adsorberet difteri- + tetanusvaccine injektionsvæske, suspension, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
adsorberet tetanusvaccine injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- + tetanusvaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- og tetanustoxoider og helcellekighostevaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- og tetanustoxoider og acellulær kighostevaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Administration of tetanus vaccine	Direct substance	False	tetanustoxoid	Inferred relationship	Some	1
Tetanus antitoxin, animal	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
humant tetanustoxoid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
encephalomyelitis - influenzavaccine - tetanustoxoid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Diphtheria and tetanus toxoids with pertussis, combined vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
adsorberet tetanustoxoid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
adsorberet tetanus- og difteritoxoid til voksne	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Equine influenza vaccine - tetanus toxoid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
adsorberet difteri- og tetanustoxoid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Clostridium perfringens type D-tetanustoxoid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
tetanustoxoid, dyr	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
encephalomyelitisvaccine - tetanustoxoid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
stivkrampevaccination, ikke nærmere specificeret	Direct substance	False	tetanustoxoid	Inferred relationship	Some	1
adsorberet tetanustoxoid 20 enheder/ml 0,5 ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 7.5ml/5ml (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Diphtheria and tetanus toxoid 0.5vial/haemophilus b conjugate injection suspension vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Diphtheria toxoid adsorbed ns/pertussis adsorbed ns/tetanus toxoid adsorbed ns injection suspension vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
adsorberet difteri- + tetanus- + kighostevaccine injektionsvæske, hætteglas a 7,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
adsorberet tetanustoxoid 10 enheder til intramuskulær anvendelse, injektionsvæske, suspension, hætteglas a 5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
adsorberet tetanustoxoid 10 enheder til intramuskulær anvendelse, injektionsvæske, suspension, sprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
adsorberet difteri- + tetanus- + kighostevaccine injektionsvæske, hætteglas a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
flydende tetanustoxoid	Is a	False	tetanustoxoid	Inferred relationship	Some
tetanus- og difteritoxoid	Is a	False	tetanustoxoid	Inferred relationship	Some
difteri- + kighoste- + tetanus- + Haemophilus influenzae type b-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri-/tetanus-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- + tetanus- + poliovaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- + tetanus- + inaktiveret poliovirusvaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- + tetanus- + kighoste- + poliovaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- + tetanus- + kighoste- + inaktiveret poliovirusvaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri-/tetanus-/kighoste-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- + tetanus- + kighoste- + polio- + Haemophilus influenzae type b-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- og tetanustoxoider og helcellekighostevaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
lavdosis difteri-/tetanus-/kighoste-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
højdosisdifteri-/tetanus-/kighoste-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
tetanustoxoid + reduceret difteritoxoid + acellulær kighostevaccine injektionsvæske, hætteglas a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- + kighoste- + tetanusvaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighostevaccine 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Haemophilus influenzae type B- + tetanusvaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Haemophilus influenzae type B-polysaccharidvaccine 10 µg + tetanustoxoid 24 µg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Haemophilus influenzae type b-polysaccharidvaccine 10 µg + tetanustoxoid 30 µg pulver til injektionsvæske, opløsning, hætteglas + solvens	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighoste-vaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigen 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
Haemophilus influenzae type b-vaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + kighostevaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt sprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- + tetanus- + kighoste- + polio- + rekombinant hepatitis B-virus-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- + tetanus- + kighoste- + polio- + rekombinant hepatitis B-virus- + rekombinant Haemophilus influenzae type b-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulært kighostetoxoid 25 µg inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some
difteri- + tetanus- + Haemophilus influenzae type b-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanustoxoid	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set

POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1764329010	Tetanus toxoid (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1776350017	Tetanus toxoid	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3265071000005114	tetanustoxoid	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)